🧠 PART 1 — BIG PICTURE: STEROIDS vs PROSTAGLANDINS
Core Concept
Both are lipid hormones, but fundamentally different in:
Feature | Steroids | Prostaglandins |
Substrate | Cholesterol | Arachidonic acid |
Enzymes | CYP + HSD | PLA2 + COX + PG synthases |
Receptors | Intracellular nuclear receptors | Cell surface GPCR |
Mechanism | Genomic (DNA transcription) | Second messenger |
Speed | Slow (hours–days) | Rapid (seconds–minutes) |
Action type | Systemic endocrine | Local paracrine/autocrine |
In pregnancy, these must coordinate precisely to regulate myometrial contraction timing.
🧠 PART 2 — STEROID HORMONES
2.1 Classification
Steroids are divided into:
- Corticosteroids → adrenal cortex
- Gonadal steroids → ovary or testis
All derived from cholesterol.
2.2 Cholesterol Sources (4 Major)
Steroidogenic cells obtain cholesterol from:
- De novo synthesis (from acetate)
- Plasma membrane
- Intracellular lipid droplets (cholesteryl esters)
- Plasma LDL cholesterol
All must ultimately reach mitochondria.
2.3 Rate-Limiting Step in Steroidogenesis
Critical Reaction
Cholesterol (27C) → Pregnenolone (21C)
Enzyme:
CYP11A1 (P450scc)
Located in inner mitochondrial membrane facing matrix
⚠️ Important implication:
Cholesterol must cross aqueous intermembrane space.
2.4 Cholesterol Transport Machinery
Requires:
- StAR protein
- Mitochondrial peripheral benzodiazepine receptor
- Voltage-dependent anion channel activation → Cl⁻ efflux
- Membrane apposition
Hormones that increase StAR:
- LH
- FSH
- hCG
- ACTH
2.5 Clinical Correlation — Lipoid Congenital Adrenal Hyperplasia
Failure of StAR → no cholesterol entry into mitochondria
Consequences:
- Accumulation of cholesteryl esters in adrenal cortex
- No corticosteroid synthesis
- Usually lethal in utero
- If born:
- Poor lung inflation (no fetal glucocorticoids)
- Salt-wasting crisis (no aldosterone)
🧠 PART 3 — STEROIDOGENIC ENZYMES
Two enzyme classes only:
3.1 CYP Enzymes
Functions:
- Hydroxylation → increase solubility
- Some act as lyases:
- CYP11A1
- CYP17A
Mechanism:
- Requires NADPH
- Electron transfer via:
- Ferredoxin reductase
- Ferredoxin
- To haem centre
3.2 HSD Enzymes
Types:
- 3β-HSD
- 17β-HSD
Functions:
- Oxidoreductases (short-chain alcohol dehydrogenases)
- Modify alcohol/ketone groups
3β-HSD
- Converts:
- Pregnenolone → Progesterone
- DHEA → Androstenedione
- Acts as Δ5 → Δ4 isomerase
Double bond shifts:
C5–6 → C4–5
17β-HSD
- Reduces C17 ketone
- Converts:
- Androstenedione → Testosterone
- Estrone → Estradiol
🧠 PART 4 — TISSUE-SPECIFIC STEROIDOGENESIS
Pathway depends entirely on enzyme expression pattern.
4.1 Testis Leydig Cells
Enzymes:
- CYP11A1
- CYP17A
- 3β-HSD
- 17β-HSD
Product:
→ Testosterone
4.2 Ovarian Theca Cells
Enzymes:
- CYP11A1
- CYP17A
- 3β-HSD
Product:
→ Androstenedione
4.3 Ovarian Granulosa Cells
FSH induces:
- Aromatase (CYP19)
Converts:
Androstenedione → Estrone → Estradiol (via 17β-HSD)
4.4 Corpus Luteum
Expresses:
- CYP11A1
- 3β-HSD
- CYP17A
- CYP19
- 17β-HSD
Produces:
- Progesterone
- Estradiol
🧠 PART 5 — PLACENTA AS “INCOMPLETE ENDOCRINE GLAND”
Key missing enzyme:
CYP17A
Thus placenta cannot convert progestogens → androgens.
Estrogen production requires:
- Fetal adrenal gland
- Maternal liver
- Placenta
Important fetal steroid:
16α-hydroxyandrostenedione
→ Aromatised in placenta
→ Estriol
Estriol = Marker of fetal adrenal function
🧠 PART 6 — STEROID METABOLISM & CLEARANCE
Peripheral metabolism:
- Skin
- Bone
- Adipose tissue
Examples:
- Testosterone → DHT (5α-reductase 2) → genital virilisation
- Testosterone → Estradiol (CYP19) → epiphyseal closure
Clearance (Liver, 2-Step)
Step 1:
CYP or HSD create polar OH groups
Step 2:
Conjugation by:
- Glucuronyltransferases
- Sulphotransferases
→ Excretion in urine/faeces
🧠 PART 7 — STEROID HORMONE ACTION
7.1 Receptors
Five steroid receptors exist.
All share four domains:
- Ligand-binding domain
- DNA-binding domain (zinc fingers)
- Dimerisation domain
- Transactivation domains
7.2 Mechanism
Ligand binding →
Receptor activation →
Dimer formation (homo/hetero) →
DNA binding at response elements →
Recruit co-regulators
7.3 Co-regulators
Co-repressors
- Recruit histone deacetylase
- Condense DNA
- Repress transcription
Coactivators
- Recruit histone acetyltransferase
- Open chromatin
- Increase transcription
Speed
Slow:
6 hours → days
Because genomic
🧠 PART 8 — PROSTAGLANDINS
8.1 Substrate: Arachidonic Acid
Stored in membrane phospholipids.
Liberated by:
Phospholipase A2
Inhibited by:
Lipocortin
(which is upregulated by glucocorticoids)
8.2 COX Enzymes
Arachidonate → PG G2 → PG H2
Two forms:
- COX-1 (constitutive)
- COX-2 (inducible)
Inhibited by:
NSAIDs (indometacin, aspirin)
8.3 Prostaglandin Synthases
PGH2 → converted to:
- PGD2
- PGE2
- PGF2α
- PGI2 (prostacyclin)
8.4 Inactivation
15-hydroxyprostaglandin dehydrogenase
Oxidises 15-OH → ketone
Highly expressed in lungs
→ 65% inactivated per pulmonary pass
Result:
Short-lived, local action only
🧠 PART 9 — PROSTAGLANDIN ACTION
Despite lipid nature → act via:
GPCR (cell surface)
PGF2α
Receptor:
F-prostanoid receptor
Pathway:
PLC → IP3 → ↑Ca²⁺
PGE2
Four receptor subtypes
Pathway:
↑ cAMP → activate PKA
Opposing actions often due to different signalling.
Speed:
Seconds–minutes
Acts via modifying pre-existing proteins.
🧠 PART 10 — REGULATION OF MYOMETRIAL CONTRACTILITY
Yin–Yang balance.
10.1 Contractants
- Oxytocin (originates from uterus, not posterior pituitary)
- PGF2α
Mechanism:
Receptor → PLC → IP3 → ↑Ca²⁺
Activates:
- Myosin light chain kinase
- Ca²⁺/calmodulin kinase
Positive Feedback Loop
Oxytocin → ↑ prostaglandins
PGF2α → ↑ oxytocin receptors
Amplification loop.
Steroid Modulation
Estradiol & Cortisol increase:
- Oxytocin expression
- Oxytocin receptor
- F-prostanoid receptor
- Prostaglandin enzymes
10.2 Relaxants (Anticontractants)
Work via:
- cAMP
- cGMP
Cause:
Dephosphorylation of myosin light chain
Major Relaxant
Progesterone
Actions:
- Decreases oxytocin synthesis
- Decreases prostaglandin action
- Increases cAMP
- Decreases gap junction formation
Uses both genomic + rapid non-genomic mechanisms.
Other Relaxants
- Nitric oxide (may act independent of cGMP)
- Relaxin → ↑ cAMP
- Prostacyclin → ↑ cAMP
🧠 PART 11 — TERM LABOUR SWITCH
At term:
Placental progesterone output declines
↓ Progesterone : Estradiol ratio
Shift:
Relaxant dominance → Contractant dominance
Labour begins.





